Christine Worthen, Member of the Firm, moderates “Value-Based Cancer Care and ERISA Fiduciary Duties: How Self-Insured Employer Plans Can Navigate Regulatory, Quality, and Cost Concerns While Delivering Meaningful Benefits for Their Employees ” at the Association for Value-Based Cancer Care (ABVCC) 14th Annual Summit & Education Program, which runs from October 16 to 18.
Plan sponsors of self-insured employer plans face increasing headwinds in managing costs while providing whole-person health benefits for their employees and their families. With 2025 plan trends at 8% and price transparency in full swing, now more than ever employers need to be mindful of the choices they make as ERISA fiduciaries.
This session will provide an overview of ERISA and what it means to be a fiduciary, review cost developments/trends, and provide options for tailoring high-value cancer care benefits that provide a meaningful impact not just on the bottom line but also in the lives of employees and their families.
Panelists discuss the opportunities and challenges facing employers and delve into topics such as:
- How to balance high-value cancer care and high-performing cancer care
- How to craft an ideal cancer solution for employers: detection, survivorship, treatment
- Meeting ERISA fiduciary duties – costs, quality, community partnerships, and more
For more information and to register, please visit ABVCC.org.
Event Detail
New York Athletic Club
New York City, NY
